Recent News

Recognizing the Dangerous Effects of Blood Thinners

Anticoagulants are a powerful way to prevent blood clots and stroke in atrial fibrillation patients, as these medications work by increasing blood flow within a patient’s body. However, these medications can also cause severe internal bleeding events which can lead to a number of serious and potentially fatal health complications. When prescribed an anticoagulant medication,…

Read More...

Defective INR Device Used in Xarelto Clinical Trials

In February 2016, BMJ, a medical journal based in the United Kingdom, published a report detailing the use of a faulty device in the Xarelto clinical trials. The Alere international normalized ratio (INR) monitoring device was used to measure blood clotting in patients taking warfarin during the ROCKET-AF clinical trials. The report reveals that the…

Read More...

FDA Provides Additional Warnings for SGLT2 Inhibitors

In May, the United States Food and Drug Administration released information advising physicians and patients to be cautious about the risks related to SGLT2 inhibitors. Now, the FDA has updated the warning label for the drugs to include the risk of ketoacidosis and severe urinary tract infection. SGLT2 inhibitors, like the drug Invokana, work to…

Read More...

Xarelto Bellwether Trials to Begin in 2017

Dates have been selected for the first Xarelto multidistrict litigation hearings. Pretrial discovery and bellwether trial selection for the Xarelto multidistrict litigation (MDL) has begun.  The first trials will consist of a selection of four cases, from a pool of forty, that have been considered to represent the majority of the cases filed around the…

Read More...

FDA Increases Invokana Warnings

In September, the Food and Drug Administration (FDA) strengthened a warning that linked diabetes drug Invokana to an increased risk of bone fractures. The warning came as the result of various separate clinical studies showing that the medication reduced bone density in patients, and caused severe fractures. The FDA will continue to monitor Invokana and…

Read More...